简体中文 | 繁體中文 | English

Press Releases

2024-01-26 13:49 LambdaTest Leads the Market with Samsung Galaxy S24 Series Integration in Real Device Cloud
2024-01-26 11:50 Kenvue Declares Quarterly Cash Dividend
2024-01-26 11:45 Deutsche Telekom Awards Mavenir Cloud-Native Messaging Contracts Driving 5G Readiness Across Four Networks in Europe
2024-01-26 11:40 The Sophistication of Cybercriminals Intensifies With Emerging Strategies for Cashing in or Causing Chaos
2024-01-26 11:26 Thales and Quantinuum Launch Starter Kit to help Enterprises prepare for Post-Quantum Cryptography Changes Ahead
2024-01-26 10:43 James Cook University Singapore Selects Juniper Networks to Enable Transformative Blended Learning Experiences Powered by an AI-Driven Network
2024-01-25 14:14 IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position
2024-01-25 14:04 Nexo Sues Bulgaria for Over $3 Billion
2024-01-25 12:45 LambdaTest announces the launch of SmartUI SDK for Effortless Visual Regression Testing
2024-01-25 12:43 ReLive Biotechnologies Announces NDA Approval of SpheChon 10-70 spheroids/cm² by the HSA in Singapore, Marking a Milestone in ReLive’s Global Endeavors
2024-01-25 12:10 Newmont Strengthens Leadership Team with Appointment of Industry Leader Peter Wexler as Chief Legal Officer
2024-01-25 12:05 Rimini Street Japan Celebrates 10 Years of Extraordinary Client Service and Regional Success
2024-01-25 11:43 Summit Communications Powers the Future of Connectivity in Bangladesh with 400G Solutions from Juniper Networks
2024-01-25 11:38 The Empire State Building Rings in the Year of the Dragon with Exclusive Sunrise Experiences at the Observatory, in Partnership with Trip.com Group
2024-01-25 11:23 HD Immune GmbH Foundation and Publication of Latest Pre-Clinical Data
2024-01-24 15:25 Xsolla Curine Academy to Host Prestigious Global Game Jam 2024 in Kuala Lumpur
2024-01-24 15:23 Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development
2024-01-24 15:20 Best’s Commentary: AM Best Issues FAQ on Its Country Risk Evaluation of China Following Economic Slowdown
2024-01-24 15:17 Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations
2024-01-24 15:13 EDX Markets Launches Clearinghouse for Crypto Trading and Announces Completion of Series B Funding Round